Antitumor activity of B7-H3.CAR-T cells was found not only by using NSCLC tumor cell lines, but also by using a patient-derived xenograft NSCLC organoid model that represents a more clinically relevant surrogate in vitro of primary NSCLC lesions25–27. Here, CD276 is linked to non-small cell lung carcinoma.